PharmaForce On Air

In a twist not uncommon in 340B, the Rebate Model has been paused. Learn how this change is already causing operational challenges for some CEs.

With new HRSA details in hand, covered entities are facing two choices: panic or prepare.

Understand the challenges of managing referral capture in a rebate-based system while learning actionable approaches to sustain your specialty referral capture. 

Examine where HRSA’s 340B Rebate Model Pilot Program FAQs have provided clarity, highlight areas that remain ambiguous, and outline practical considerations to help your team prepare for January 2026.

Learn to navigate the drugs reimbursed at the Maximum Fair Price as IRA changes bring significant implications for 340B savings, compliance, and access.

How the latest executive order could impact your 340B program. Whether you're a compliance leader, pharmacy director, or finance executive, this session provides the clarity you need to navigate what’s next. 

Pharmacy access legislation could make manufacturer restrictions a thing of the past. Learn five essential 340B claims processing changes that will restore program benefits across your pharmacy network.

Learn how HRSA’s Administrative Dispute Resolution (ADR) can help entities recover potential missed savings when manufacturers are not providing the required 340B discounts.

A new 340B rebate model could reshape your cash flow overnight. Learn hidden challenges that could blindside unprepared organizations and process changes you'd need to make—fast.

Looking ahead at the evolution of manufacturer restrictions, state access bills, what proposed model changes mean for your bottom line, the Inflation Reduction Act and what covered entities need to do now.

With the election behind us, the healthcare industry is buzzing with questions about the future of the 340B Drug Pricing Program.
 

Making Sense of the New FDA Drug Supply Chain Security Act Exemptions. This webinar is your "cheat sheet" to navigating the DSCSA landscape.  

Maximize 340B efficiency and savings with strategies to offset losses from manufacturer restrictions, maximize referral capture, expand your pharmacy network, and master data submission.

Covers practical strategies to enhance 340B benefits, including operational impact of manufacturer restrictions, Contract Pharmacy Access legislation, and laws that may reshape 340B.

Discover the power of AI in 340B program management. Learn about current chatbots and audit bots, and explore future possibilities in compliance, efficiency, and cost-effectiveness.

As Mississippi bars 340B contract pharmacy restrictions, special guest Chad Netterville, Director of Rural Health Alliance and Center for Rural Health, shares insights about navigating state legislation.

Credit-based replenishment models eliminate the need for physical inventory deliveries. Explore the benefits of their potential suitability for your program.

 

A look at how the SUSTAIN 340B Act and the 340B Patients Act demonstrate a strong commitment to refining the program, ensuring it serves patients effectively while maintaining accountability. 

This webinar offers a comprehensive breakdown of the new draft SUSTAIN 340B Act legislation, dissecting its contents, advantages, and disadvantages.

Learn how joining your employee pharmacy benefits and 340B program to work hand-in-hand results in insights that will increase savings, drive down drug costs, and provide better patient care.

A comprehensive exploration of the current status of the 340B program, featuring a review of major industry trends from 2023 and key developments anticipated for 2024.

This session explores critical areas where program gaps may exist and provides actionable tactics to ensure a 100% HRSA audit pass rate. Understand the audit process, common findings, and swift remediation strategies.

A master class on maximizing your claims capture rates. Close legacy gaps and learn about the five factors that changed the calculus for clients like you. 

Discover how effective relationships thrive when CEs and Pharmacies collaborate closely. Uncover the essential components of successful partnerships.

Learn how to track the key data points that demonstrate the value of your 340B program to your community: calculate your overall savings, track patient benefits, and create an impact profile. 

A look at new 340B developments and best practices regarding pharmacy usage vs. purchasing monitoring, and how to avoid being flagged — and risk losing 340B pricing. Also learn pitfalls to avoid and ESP site features.

Discover ways to maximize savings and prevent revenue losses. Learn little-known ways that operational oversight and tracking gaps may be leaking savings. 

Are you ready to navigate the new wave of restriction policies with minimal impact? We examine the most important key points to ensure your program is up-to-date and compliant.

Learn about often-overlooked strategies to optimize your 340B program and mitigate losses. Don't let manufacturer exclusions hold you back – take action to maximize your savings. 

In this webinar we will cover the recent manufacturer restrictions in the 340B market, including the latest legal updates, new restrictions, and lessons learned that will help covered entities navigate this new landscape.

Get your 340B program off to its best start in 2023 and keep it running strong. Learn the foundational basics and even a few master-level moves for maximizing capture and avoiding an audit.

Learn how to manage your 340B data submission—from pulling TPA claims and submitting data to monitoring wholesaler price and pharmacy usage to avoid being flagged.

Complete patient data is the core of a compliant 340B program. Learn how 340B patient data feeds work, how they are processed, and how to troubleshoot your 340B program data to capture all 340B-eligible claims. 

Learn best practices for managing drug spend—from account set-up, to purchasing strategies, and TPA configurations. We’ll identify the metrics and KPIs to track as well as processes to decrease unnecessary WAC spend.

Explore different ways to analyze Covered Entities' operational program expenses and tips on how to reduce yours. From third-party administrators to a contract pharmacy's dispensing fees, you will learn best practices for evaluating expenses.

Are you an entity that has been impacted by the 10+ manufacturers that are now blocking 340B pricing at contract pharmacies? Learn five strategies you can implement right away to recoup part of the loss on your savings.

A step-by-step guide to optimizing your 340B program and ensuring you’re capturing all possible claims. 

Achieve a high-performing 340B program with operational optimization, coordinated TPA support, as well as methods for tracking new program changes and ongoing performance.

The 340B program is changing quickly, creating legal, policy, and operational uncertainty for covered entities. This session explains the latest developments, what they mean for your program, where you may be exposed or have opportunity, and what actions leading organizations are taking to stay compliant, protect savings, and maintain control.